Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

admin1 month ago01 mins

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com